The Oncologic Endocrinology fellowship is a one-year program accepting one fellow per year. Our program is the only one in the nation to provide advanced training for the evaluation and treatment of endocrine neoplasias. Fellows will acquire the skills and knowledge base for evaluating and treating patients with these complex endocrine tumors.
Faculty with the Department of Endocrine Neoplasia and Hormonal Disorders evaluate, manage and investigate a wide spectrum of tumors of the thyroid, adrenals, parathyroid, pituitary, pancreas and hereditary endocrine syndromes in both adults and children. The Endocrine Center has well-established collaborative relationships with head and neck surgery, surgical endocrinology, medical oncology, genetics, radiology and pathology. This unique concentration of expertise provides a training experience that will develop future leaders in the field of endocrine neoplasia.
The curriculum includes outpatient and inpatient management of patients with complicated endocrine neoplasias and hormonal disorders, including patients enrolled into Phase I-III clinical trials. Rotations with non-endocrine specialties such as medical oncology, surgery, pathology and radiology are included.
Research activities will be encouraged with opportunities to present at local, national or international meetings. Academic opportunities will include routine conferences and the education of medical students, residents, or fellows.
How to Apply
- Apply to this program using the DISCOVER online application system
All applicants should have completed a U.S. or Canada-accredited fellowship in endocrinology, diabetes and metabolism or medical oncology in good standing, and must have an active license or be eligible for a license from the Texas Medical Board.
Graduates of foreign medical schools and specialty training programs in endocrinology or medical oncology must have a valid certificate from the Educational Commission for Foreign Medical Graduates (ECFMG) prior to appointment, and must be eligible for an appropriate visa.
Required application materials:
- Completion of an application form
- Personal statement (including goals and reason for pursuing an Oncologic Endocrine Fellowship)
- Curriculum vitae
- Two letters of recommendation, plus one from the fellowship program director
- Medical school transcript
After a review of the application package, a personal interview with faculty members will be arranged with outstanding candidates.
Dr. Danica Vodopivec is the current Oncologic Endocrinology Fellow at MD Anderson Cancer Center in the Department of Endocrine Neoplasia and Hormonal Disorders. After obtaining her medical degree at Universidad de Guayaquil in Ecuador, she completed an Internal Medicine residency at Lahey Clinic/Tufts University in Burlington, MA. More recently, she graduated as an endocrinologist at Boston Medical Center/Boston University School of Medicine in Boston, MA. Throughout her training years she has participated in clinical and bench research dedicated to parathyroid neoplasia, multiple endocrine neoplasia syndrome, and tyrosine kinase inhibitors resistance mechanisms in thyroid cancer. Her scholarly activities have resulted into several peer-reviewed articles, book chapters, and quality improvement projects dedicated to better serve the community of patients presenting with various types of endocrine neoplasia. In addition, she served as Fellow Representative for the New England Endocrine Alliance (NEEA) society. During her 2-year term, she co-founded a novel virtual learning series guided to supplement the education of endocrine fellows from the New England region during the COVID-19 pandemic. These didactic series project gained not only regional but also national recognition by other major endocrinology societies. She was recently selected to be part of the 2021 American Thyroid Association (ATA) Board of Directors where she will be serving as Trainee Observer. Dr. Vodopivec plans to continue a career in academia, focusing on underserved population and clinical research, particularly translational drug development in advanced thyroid cancer.
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.